Brainsway's Deep TMS device gets FDA OK for depression treatment

01/10/2013 | Globes (Israel)

The FDA has cleared Brainsway's Deep TMS device for use in treating patients with depression who don't respond to drugs during an episode. The clearance paves the way for Brainsway to enter a key market in the U.S., which the firm says is worth billions of dollars per year.

View Full Article in:

Globes (Israel)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC